What Are the Treatments for Wet AMD?

Wet age-related macular degeneration, often shortened to wet AMD, sounds like something that should be fixed with a towel. Unfortunately, it is more serious than that. Wet AMD happens when abnormal blood vessels grow under or into the macula, the part of the retina responsible for sharp central vision. These fragile vessels can leak fluid or blood, causing blurry vision, wavy lines, dark spots, and difficulty reading, driving, recognizing faces, or enjoying the tiny print on a restaurant menu without feeling betrayed.

The good news is that wet AMD is treatable. While there is currently no guaranteed cure that makes the condition disappear forever, modern wet AMD treatments can slow vision loss, stabilize the retina, and in some cases improve vision when treatment begins early. The main treatment is anti-VEGF therapy, usually given as an injection into the eye. Yes, that sentence makes many people blink twice. But the procedure is typically quick, numbed, and far less dramatic than it sounds.

This guide explains the major treatment options for wet AMD, how they work, what patients can expect, and why regular follow-up is just as important as the medicine itself.

Understanding Wet AMD Before Choosing Treatment

Age-related macular degeneration has two main forms: dry AMD and wet AMD. Dry AMD is more common and usually progresses slowly. Wet AMD is less common but often more aggressive. It develops when new blood vessels grow where they should not, leak into the retina, and damage the macula.

The macula is small, but it has a big job. It helps you see fine details directly in front of you. When wet AMD affects the macula, side vision usually remains, but central vision may become distorted or blurred. That is why people with wet AMD may still walk around a room but struggle to read a clock, see a loved one’s face clearly, or thread a needle without declaring war on the thread.

Because wet AMD can change quickly, early diagnosis and prompt treatment matter. Common diagnostic tools include a dilated eye exam, optical coherence tomography, fluorescein angiography, and sometimes OCT angiography. These tests help a retina specialist see fluid, bleeding, swelling, and abnormal blood vessels.

Anti-VEGF Injections: The Main Treatment for Wet AMD

The leading treatment for wet AMD is anti-VEGF therapy. VEGF stands for vascular endothelial growth factor, a protein that encourages new blood vessel growth. In wet AMD, too much VEGF contributes to abnormal, leaky blood vessels. Anti-VEGF medications block this signal, helping reduce leakage, swelling, and further retinal damage.

Common Anti-VEGF Medicines

Several anti-VEGF medicines are used for wet AMD. These may include:

• Aflibercept, sold as Eylea and Eylea HD
• Ranibizumab, sold as Lucentis
• Faricimab-svoa, sold as Vabysmo
• Brolucizumab, sold as Beovu
• Bevacizumab, sold as Avastin, used off-label for many eye conditions
• Ranibizumab via port delivery system, sold as Susvimo for selected patients

Each medication has its own dosing schedule, benefits, limitations, cost considerations, and safety profile. Some patients respond beautifully to one drug and less impressively to another. Retina specialists often adjust the treatment plan based on OCT imaging, vision changes, injection history, fluid activity, and how long the eye stays stable between visits.

What Happens During an Eye Injection?

Although “eye injection” sounds like a phrase invented by a horror movie intern, the actual process is usually short. The doctor numbs the eye, cleans the surface carefully to reduce infection risk, may use a small device to keep the eyelids open, and injects the medicine into the vitreous, the gel-like area inside the eye. The injection itself usually takes only seconds.

Afterward, patients may notice mild irritation, watering, a scratchy feeling, a red spot on the white of the eye, or small floaters. These effects often improve quickly. However, severe pain, worsening vision, increasing redness, or light sensitivity after an injection should be reported immediately because rare complications such as infection or retinal detachment need urgent care.

How Often Are Wet AMD Injections Needed?

At the beginning of treatment, many people receive injections about once a month. This early phase helps dry up fluid and control active blood vessel leakage. After the retina becomes more stable, the specialist may adjust the interval.

Common treatment approaches include:

Fixed Dosing

With fixed dosing, injections are given at regular intervals, such as every four, eight, twelve, or sixteen weeks, depending on the medication and response. This schedule is straightforward and may reduce the risk of undertreatment, but it can mean more visits than some patients need.

Pro Re Nata, or “As Needed,” Treatment

In an as-needed approach, the patient is monitored regularly and treated when signs of fluid or disease activity return. This can reduce injections for some people, but it requires careful follow-up. Skipping visits is not a heroic act of independence; it is more like letting a small roof leak become an indoor waterfall.

Treat-and-Extend

Treat-and-extend is widely used in retina clinics. The patient receives an injection at each visit, and if the retina remains dry and stable, the interval between visits is gradually extended. If fluid returns, the interval is shortened. This method aims to balance disease control with fewer appointments.

Longer-Lasting Wet AMD Treatment Options

One of the biggest challenges in wet AMD treatment is treatment burden. Many patients are older, may not drive, and may need family support to attend appointments. Longer-lasting medications and delivery systems are designed to reduce the number of visits while maintaining vision.

High-Dose Aflibercept

Eylea HD is a higher-dose form of aflibercept. In appropriate patients, it may allow longer intervals between injections after the eye has responded well. Some patients may still need more frequent care, while others can safely stretch visits further under close supervision.

Faricimab

Faricimab targets both VEGF-A and angiopoietin-2 pathways, which are involved in blood vessel leakage and instability. For selected patients, it may support extended dosing intervals. The practical goal is simple: fewer appointments, less stress, and less time rearranging life around the retina clinic.

Susvimo Port Delivery System

Susvimo is a refillable implant that continuously releases ranibizumab into the eye. Instead of regular injections, the device is surgically placed and refilled periodically. It is not for everyone, and it requires a specific discussion about surgical risks, benefits, follow-up, and candidacy. For some people with wet AMD who have already responded to anti-VEGF therapy, it may be an option to reduce frequent injection visits.

Photodynamic Therapy for Wet AMD

Photodynamic therapy, or PDT, is a less common treatment today but still has a role in selected cases. It uses a light-sensitive medicine called verteporfin. The medicine is injected into a vein and travels through the bloodstream. A special cold laser is then aimed at the abnormal blood vessels in the eye, activating the medicine and helping close the leaky vessels.

PDT is not usually the first-line treatment for typical wet AMD because anti-VEGF therapy is more effective for most patients. However, it may be considered when certain blood vessel patterns are present, when anti-VEGF response is incomplete, or when a retina specialist believes combination therapy may help.

Laser Photocoagulation

Laser photocoagulation was used more often before anti-VEGF therapy changed the landscape. This treatment uses a hot laser to seal or destroy abnormal leaking blood vessels. Today, it is rarely used for wet AMD because the laser can also damage nearby retinal tissue and may create permanent blind spots.

Still, laser treatment may be considered in unusual cases, especially when abnormal vessels are located away from the center of the macula. It is a specialized decision, not a casual “zap it and hope” situation.

Combination Therapy

Some patients do not respond fully to one treatment alone. In these cases, a retina specialist may consider combination therapy, such as anti-VEGF injections plus photodynamic therapy. This is more common in complex or resistant cases, not as a standard first step for every patient.

Combination treatment may be discussed when fluid keeps returning, bleeding continues, or imaging shows a specific type of abnormal vessel pattern. The goal is to improve control of leakage and reduce repeated disease activity.

Do Vitamins Treat Wet AMD?

Vitamins do not replace anti-VEGF injections for active wet AMD. The well-known AREDS2 supplement formula may help certain people with intermediate AMD reduce the risk of progression to advanced AMD. It may also be recommended for some patients who have late AMD in one eye to help protect the other eye. However, AREDS2 does not dry retinal fluid, close abnormal vessels, or treat active wet AMD in the way anti-VEGF therapy does.

The AREDS2 formula commonly includes vitamin C, vitamin E, zinc, copper, lutein, and zeaxanthin. Current and former smokers are generally advised to avoid older formulas that contain beta-carotene because of lung cancer risk. Patients should talk with an eye doctor before starting supplements, especially if they take other medications or have other health conditions.

Lifestyle Support: Helpful, But Not a Substitute for Treatment

Lifestyle choices cannot replace medical treatment for wet AMD, but they can support overall eye health and reduce risk factors. Important steps include quitting smoking, managing blood pressure, controlling cholesterol and diabetes, eating a nutrient-rich diet, staying physically active, and wearing sunglasses that protect against ultraviolet light.

A diet that supports eye health often includes leafy greens, colorful vegetables, fruit, legumes, nuts, and fish rich in omega-3 fatty acids. Think of it as feeding the retina like it is a VIP guest, not tossing it the nutritional equivalent of couch crumbs.

Low-Vision Rehabilitation

Even with treatment, some people experience permanent vision changes. That does not mean independence is over. Low-vision rehabilitation helps people use their remaining vision more effectively. Services may include magnifiers, special lighting, contrast training, electronic reading devices, mobility strategies, home safety adjustments, and training for daily tasks.

Low-vision care is not “giving up.” It is problem-solving. If wet AMD makes reading, cooking, paying bills, using a phone, or navigating stairs more difficult, low-vision tools can make everyday life safer and less frustrating.

How Doctors Decide the Best Wet AMD Treatment

There is no single perfect treatment plan for every person. A retina specialist may consider:

• How much fluid or bleeding is visible on imaging
• How quickly vision changed
• Whether one or both eyes are affected
• Previous response to anti-VEGF injections
• Other eye conditions, such as glaucoma or cataracts
• Risk of side effects
• Cost, insurance coverage, and access to care
• Transportation and caregiver support

Sometimes the first medicine works well. Other times, the doctor may switch medications, adjust the dosing schedule, or combine therapies. The treatment plan is more like tailoring a suit than buying one-size-fits-all socks.

What Patients Should Expect Over Time

Wet AMD treatment is usually long-term. Many patients need ongoing injections or monitoring for years. Some eyes remain stable with extended intervals, while others need closer treatment. Missing appointments can allow fluid to return and may increase the risk of permanent vision loss.

Patients may be asked to monitor vision at home using an Amsler grid or digital monitoring tools. New distortion, dark spots, sudden blurriness, or changes in reading ability should be reported promptly. Wet AMD is one condition where “I’ll wait and see” can be risky, because waiting may mean seeing less.

Possible Risks and Side Effects of Treatment

Most anti-VEGF injections are well tolerated, but no medical treatment is risk-free. Common temporary effects include eye redness, irritation, tearing, mild discomfort, and floaters. Rare but serious risks include infection inside the eye, retinal detachment, increased eye pressure, inflammation, bleeding, and allergic reactions.

Some medications have specific safety considerations. For example, brolucizumab has been associated with rare but serious inflammation and retinal blood vessel problems, so doctors carefully weigh benefits and risks. Patients should always tell their retina specialist about pain, worsening redness, light sensitivity, or sudden vision decline after treatment.

Questions to Ask a Retina Specialist

Patients and caregivers can make appointments more productive by asking clear questions, such as:

• Which wet AMD treatment do you recommend for my eye, and why?
• How much fluid or bleeding do you see on my scan?
• How often will I need injections at first?
• Could my treatment interval be extended later?
• What symptoms after an injection should make me call immediately?
• Would AREDS2 supplements be appropriate for me?
• Should I be referred for low-vision rehabilitation?

Experiences Related to Wet AMD Treatment

For many people, the hardest part of wet AMD treatment is not only the medicine; it is the emotional adjustment. The diagnosis can feel frightening. One week, a person may be reading the morning paper comfortably. The next, straight lines on the bathroom tile look wavy, faces seem less sharp, or a dark smudge appears in the center of vision. That kind of change can make anyone feel uneasy.

A common patient experience is surprise at how manageable injections become. Before the first appointment, people often imagine the worst. They picture a huge needle, dramatic music, and perhaps a nurse whispering, “Be brave.” In reality, most retina clinics perform these injections every day. The eye is numbed, the area is cleaned, the injection is quick, and the staff usually talks patients through each step. Many people later say the anticipation was worse than the procedure.

Another real-world experience is learning that treatment is a routine, not a one-time event. Wet AMD often requires repeated visits. At first, this can feel discouraging. But many patients come to see the schedule as vision maintenance, similar to caring for blood pressure, diabetes, or a car that insists on regular oil changes. The goal is to keep the retina as dry and stable as possible.

Caregivers also play a major role. A spouse, adult child, friend, or neighbor may help with transportation after injections, medication lists, appointment reminders, and emotional support. Simple planning can reduce stress: keep a calendar, bring sunglasses for light sensitivity, ask the clinic how long visits usually take, and write down questions before the appointment. A small notebook can become surprisingly powerful when medical details start flying around like confetti.

Some people experience temporary irritation after injections, especially from the antiseptic used to clean the eye. Artificial tears, if approved by the doctor, may help with scratchiness. Patients should avoid rubbing the eye and follow clinic instructions carefully. If pain is severe or vision worsens, it is important to call the doctor rather than hoping it magically disappears by dinner.

Living with wet AMD may also require practical home changes. Better lighting near reading areas, high-contrast labels, large-print books, voice assistants, magnifying apps, and organized spaces can make daily tasks easier. For example, using bold stickers on appliance buttons or placing contrasting tape on stair edges may reduce frustration and improve safety. These small changes do not make the diagnosis vanish, but they can give people back a sense of control.

Emotionally, patients may need time to adjust. It is normal to feel worried, annoyed, or even angry. Vision is deeply connected to independence. Support groups, low-vision specialists, and honest conversations with family can help. The most encouraging message is this: wet AMD is serious, but treatment has changed the outlook dramatically. With prompt care, consistent monitoring, and a personalized treatment plan, many people continue reading, cooking, traveling, using technology, and enjoying life with fewer “Where did I put my glasses?” mysteries than expected.

Conclusion

Wet AMD is a fast-moving eye condition, but modern treatment gives patients a real chance to preserve vision. Anti-VEGF injections are the foundation of care, while longer-lasting medications, port delivery systems, photodynamic therapy, laser treatment, supplements for selected AMD stages, and low-vision rehabilitation may all play a role depending on the person. The best results usually come from early diagnosis, consistent follow-up, and a treatment plan tailored by a retina specialist.

If wet AMD has entered the conversation, do not panic, ignore it, or ask the internet to be your retina doctor. Use reliable information, ask good questions, and work closely with an eye care team. The sooner wet AMD is treated, the better the chance of protecting the central vision that makes reading, faces, details, and everyday independence possible.